This Article Full Text (OnlineFirst[PDF]) All Versions of this Article: 0009922807310249v1 47/5/435    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lanier, B. Q. Search for Related Content PubMed PubMed Citation Articles by Lanier, B. Q. Social Bookmarking                   What's this?

Use of Intranasal Corticosteroids in the Management of Congestion and Sleep Disturbance in Pediatric Patients With Allergic Rhinitis

^* To whom correspondence should be addressed. E-mail: boblaniermd{at}askdrbob.com.

	Abstract

Allergic rhinitis affects a large number of children and exerts a considerable socioeconomic impact. It is underdiagnosed and inadequately treated, which predisposes children to potentially serious comorbidities. Allergic rhinitis symptoms may create nighttime breathing problems and sleep disturbances and have a negative effect on a child’s ability to learn in the classroom. Although antihistamines have shown efficacy in relieving many symptoms, they have little effect on nasal congestion. This article summarizes the advantages of intranasal corticosteroids, including their effectiveness against congestion and excellent safety profile. Intranasal corticosteroids with minimal systemic bioavailability provide topical drug delivery that minimizes the potential for systemic side-effects.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?